FDA clears first new weight-loss pill in 13 years - ARNA
The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.
Despite only achieving modest weight loss in clinical studies, the drug appeared safe enough to win the FDA's endorsement, amid calls from doctors for new weight-loss treatments.
The agency cleared the pill Wednesday for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol.
The golden age for foreclosure squatters may soon be coming to an end now that the $26 billion mortgage settlement has been approved.
The settlement, agreed to by the nation's five largest mortgage lenders, is expected to speed up the foreclosure process by providing stricter guidelines for the banks to follow when repossessing homes.
JP Morgan, Wells Fargo Earnings Top Estimates: Key Takeaways
Today marks the start of the earnings reports that really matter --the bank stocks. This morning we heard from two of the biggest.
Wells Fargo (WFC) and JP Morgan (JPM) reported their results for the first quarter, both beating expectations, albeit with the ever present "noise" familiar to shareholders of big banks.
3 Things That Will Change After Facebook's IPO, and 2 Things That Won't
Conventional wisdom says that everything changes once a company goes public. Instead of helming your own ship, you now have to kowtow to the voracious Wall Street masters, ever hunting for bigger and better quarterly earnings. You have to play nice with the press, for fear of bad news leading to a short of your stock.